Skip to main content

Institutional intelligence for Global Health Ltd.

Cross-view mutual fund activity and super-investor shareholding · Jun 2026 SHP.

Ownership breakdown

Category totals from the official quarterly Shareholding Pattern filing (Jun 2026). Sums to 100.00%.

  • Promoters33.00%
  • FII9.46%
  • Mutual Funds16.03%
  • DII (ex-MF)0.86%
  • Retail & others40.65%
  • 1% Club 25.45%(subset)

Super Investors and 1% Club names below are disclosed holders at or above 1%. They are subsets of the categories above, not additive. View filing

Holder details (≥1% disclosed names)

Retail & others

Holders below 1% disclosure threshold and public non-institutions

40.65%

SEBI requires naming only shareholders with ≥1% stake. The remaining 40.65% includes retail investors, small HNIs, employee trusts, and other holders below the disclosure threshold — aggregated in the official filing.

Promoters

Promoter & promoter group

33.00%1 named
HolderStakeSharesValue (₹ Cr)
33.00%8,87,25,457₹11.78k Cr

1% Club — Individuals & others

Non-promoter ≥1% holders not matched to a curated profile

25.45%4 named
HolderStakeSharesValue (₹ Cr)
10.04%2,70,00,097₹3.59k Cr
6.58%1,77,05,182₹2.35k Cr
5.30%1,42,36,951₹1.89k Cr
3.53%94,97,519₹1.26k Cr

Mutual Funds

Domestic mutual funds & UTI

16.03%3 named
HolderStakeSharesValue (₹ Cr)
2.01%54,09,881₹718.4 Cr
1.83%49,09,255₹652.0 Cr
1.06%28,56,510₹379.3 Cr

FII / FPI

Foreign portfolio investors

9.46%3 named
HolderStakeSharesValue (₹ Cr)
14.84%3,99,00,990₹5.30k Cr
3.17%85,28,455₹1.13k Cr
1.86%50,00,000₹664.0 Cr

DII (other)

Insurance, banks, AIF, other domestic institutions

0.86%No names

No named holders ≥1% in this bucket.

Super Investors

Curated tracked investor profiles

No names

No curated super investor holds ≥1% in the latest filing. See FII, DII, and mutual fund holders in the sections above.

Shareholding data sourced from NSE/BSE regulatory filings. Category chart uses official filing totals; named holder lists include every disclosed ≥1% position. Not investment advice. See our disclaimer and methodology.